{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:26:51Z","timestamp":1793406411696,"version":"4.5.0"},"reference-count":169,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1136\/jnnp-2014-309697","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:48:53Z","timestamp":1423788533000},"page":"973-985","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":384,"title":["Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype"],"prefix":"10.1136","volume":"86","author":[{"given":"Emily K","family":"Mathey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna B","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A C","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J","family":"Armati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce V","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P James B","family":"Dyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy S-Y","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,2,12]]},"reference":[{"key":"key-10.1136\/jnnp-2014-309697-1","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1531-8249(199912)46:6<910::AID-ANA14>3.0.CO;2-2","article-title":"Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia","volume":"46","author":"McLeod","year":"1999","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/jnnp.2007.114868","article-title":"Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy","volume":"78","author":"Chio","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-309697-3","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/jnnp.2007.128132","article-title":"Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population","volume":"79","author":"Iijima","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-309697-4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.66.5.677","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England","volume":"66","author":"Lunn","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-309697-5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ene.12190","article-title":"Epidemiology of chronic inflammatory neuropathies in southeast England","volume":"21","author":"Mahdi-Rogers","year":"2014","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mus.21206","article-title":"Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population","volume":"39","author":"Rajabally","year":"2009","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00415-003-1068-2","article-title":"Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients","volume":"250","author":"Busby","year":"2003","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1529-8027.2010.00251.x","article-title":"A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"15","author":"Viala","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2014-309697-10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-510X(99)00317-2","article-title":"The spectrum of chronic inflammatory demyelinating polyneuropathy","volume":"173","author":"Rotta","year":"2000","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-309697-11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.23821","article-title":"Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity?","volume":"48","author":"Ayrignac","year":"2013","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000052136","article-title":"Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves","volume":"45","author":"Ohkoshi","year":"2001","journal-title":"Eur Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.48.2.321","article-title":"Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.32.9.958","article-title":"Multifocal demyelinating neuropathy with persistent conduction block","volume":"32","author":"Lewis","year":"1982","journal-title":"Neurology"},{"issue":"(Pt 3)","key":"key-10.1136\/jnnp-2014-309697-15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/119.3.765","article-title":"Focal upper limb demyelinating neuropathy","volume":"119","author":"Thomas","year":"1996","journal-title":"Brain"},{"issue":"(Pt 6)","key":"key-10.1136\/jnnp-2014-309697-16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/brain\/110.6.1617","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases","volume":"110","author":"McCombe","year":"1987","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-17","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","article-title":"Distinguishing acute-onset CIDP from fluctuating Guillain-Barr\u00e9 syndrome: a prospective study","volume":"74","author":"Ruts","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00415-003-1096-y","article-title":"Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barr\u00e9 syndrome","volume":"250","author":"Odaka","year":"2003","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/B978-0-444-52902-2.00022-9","article-title":"Chronic inflammatory demyelinative polyneuropathy","volume":"115","author":"Said","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jns5.12053","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go","volume":"19","author":"Nobile-Orazio","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2014-309697-21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.55.8.677","article-title":"\u201cChronic sensory demyelinating neuropathy\u201d: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy","volume":"55","author":"Oh","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-309697-22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/CND.0b013e31822484fb","article-title":"Chronic inflammatory pure sensory polyradiculoneuropathy: a rare CIDP variant with unusual electrophysiology","volume":"13","author":"Rajabally","year":"2012","journal-title":"J Clin Neuromuscul Dis"},{"key":"key-10.1136\/jnnp-2014-309697-23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s004150050531","article-title":"Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study","volume":"246","author":"van Dijk","year":"1999","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-24","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/01.WNL.0000142507.12763.58","article-title":"Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia","volume":"63","author":"Sinnreich","year":"2004","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-25","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/mus.21078","article-title":"Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy","volume":"38","author":"Yiannikas","year":"2008","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","article-title":"Distal acquired demyelinating symmetric neuropathy","volume":"54","author":"Katz","year":"2000","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1468-1331.2010.03312.x","article-title":"Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases","volume":"18","author":"Larue","year":"2011","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-29","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s004150170093","article-title":"Pure motor chronic inflammatory demyelinating polyneuropathy","volume":"248","author":"Sabatelli","year":"2001","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00415-009-5386-x","article-title":"Motor-dominant chronic inflammatory demyelinating polyneuropathy","volume":"257","author":"Kimura","year":"2010","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(00)00493-7","article-title":"Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy","volume":"184","author":"Hattori","year":"2001","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-309697-32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/mus.21199","article-title":"Lewis-sumner syndrome of pure upper-limb onset: diagnostic, prognostic, and therapeutic features","volume":"39","author":"Rajabally","year":"2009","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q","article-title":"Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome","volume":"22","author":"Saperstein","year":"1999","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-34","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/brain\/awh222","article-title":"Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome","volume":"127","author":"Viala","year":"2004","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1600-0404.1990.tb01011.x","article-title":"Focal neuropathy preceding chronic inflammatory demyelinating polyradiculoneuropathy by several years","volume":"81","author":"Verma","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"key-10.1136\/jnnp-2014-309697-36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mus.23541","article-title":"Focal CIDP presenting as chronic progressive monomelic sensory neuropathy","volume":"47","author":"Ayrignac","year":"2013","journal-title":"Muscle Nerve"},{"issue":"(Suppl)","key":"key-10.1136\/jnnp-2014-309697-37","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-38","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/brain\/awu158","article-title":"Early identification of \u2018acute-onset\u2019 chronic inflammatory demyelinating polyneuropathy","volume":"137","author":"Sung","year":"2014","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-39","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archneur.1992.00530300044009","article-title":"Subacute idiopathic demyelinating polyradiculoneuropathy","volume":"49","author":"Hughes","year":"1992","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-40","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/01.WNL.0000096166.28131.4C","article-title":"Subacute inflammatory demyelinating polyneuropathy","volume":"61","author":"Oh","year":"2003","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-41","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1212\/01.WNL.0000162047.89440.B9","article-title":"Subacute inflammatory demyelinating polyneuropathy in children","volume":"64","author":"Rodriguez-Casero","year":"2005","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1529-8027.2010.00278.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2014-309697-43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0b013e3181ccc6b9","article-title":"Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study","volume":"74","author":"Niermeijer","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.410360313","article-title":"Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy","volume":"36","author":"Nobile-Orazio","year":"1994","journal-title":"Ann Neurol"},{"issue":"(Pt 4)","key":"key-10.1136\/jnnp-2014-309697-45","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/brain\/123.4.710","article-title":"Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies","volume":"123","author":"Nobile-Orazio","year":"2000","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-46","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1468-1331.2011.03380.x","article-title":"Neuropathy and paraproteins: review of a complex association","volume":"18","author":"Rajabally","year":"2011","journal-title":"Eur J Neurol"},{"issue":"(Pt 5)","key":"key-10.1136\/jnnp-2014-309697-47","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/brain\/117.5.941","article-title":"Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside","volume":"117","author":"Kaku","year":"1994","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-48","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1212\/WNL.43.7.1304","article-title":"Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS","volume":"43","author":"Suarez","year":"1993","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1468-1331.2003.00687.x","article-title":"Polyneuropathy associated with IgG\/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases","volume":"10","author":"Magy","year":"2003","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-50","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jns.2007.09.020","article-title":"How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?","volume":"266","author":"Nobile-Orazio","year":"2008","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-309697-52","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/mus.22167","article-title":"Canomad presenting without ophthalmoplegia and responding to intravenous immunoglobulin","volume":"44","author":"Kam","year":"2011","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","article-title":"Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"83","author":"Nasu","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-309697-54","first-page":"443","article-title":"Neuropathy and monoclonal gammopathy","volume-title":"Handbook of clinical neurology","author":"Nobile-Orazio","year":"2013"},{"key":"key-10.1136\/jnnp-2014-309697-55","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4","article-title":"Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome","volume":"21","author":"Watanabe","year":"1998","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1529-8027.2010.00290.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2014-309697-57","first-page":"429","article-title":"Multifocal Motor Neuropathy","volume-title":"Handbook of clinical neurology","author":"Arcila-Londono","year":"2013"},{"key":"key-10.1136\/jnnp-2014-309697-58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnen\/63.2.129","article-title":"Multifocal motor neuropathy: pathologic alterations at the site of conduction block","volume":"63","author":"Taylor","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-59","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<900::AID-MUS9>3.0.CO;2-Y","article-title":"Natural history of 46 patients with multifocal motor neuropathy with conduction block","volume":"23","author":"Taylor","year":"2000","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-60","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1212\/WNL.49.5.1289","article-title":"Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates","volume":"49","author":"Pestronk","year":"1997","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-61","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.45.8.1570","article-title":"Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis","volume":"45","author":"van Schaik","year":"1995","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-62","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1212\/WNL.0b013e3181ff94c2","article-title":"Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features","volume":"75","author":"Cats","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1468-1331.2012.03767.x","article-title":"Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy","volume":"20","author":"Galban-Horcajo","year":"2013","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/mus.20296","article-title":"Multifocal motor neuropathy: current concepts and controversies","volume":"31","author":"Nobile-Orazio","year":"2005","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1468-1331.1999.610071.x","article-title":"Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies","volume":"6","author":"Willison","year":"1999","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-66","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.57.7.778","article-title":"Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin","volume":"57","author":"Donaghy","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-309697-67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mus.24088","article-title":"Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy","volume":"50","author":"Breiner","year":"2014","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-68","article-title":"Which criteria for research in CIDP? An analysis of current practice","author":"Rajabally","year":"2014","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-69","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(76)90213-6","article-title":"Chronic relapsing polyneuritis","volume":"27","author":"Prineas","year":"1976","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-309697-70","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1212\/01.wnl.0000188879.19900.b7","article-title":"Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP","volume":"65","author":"Sommer","year":"2005","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-71","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/WNL.53.4.837","article-title":"The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy","volume":"53","author":"Bosboom","year":"1999","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-5728(86)90059-7","article-title":"Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy","volume":"13","author":"Pollard","year":"1986","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-73","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","article-title":"Inflammatory infiltrates in sural nerve biopsies in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating neuropathy","volume":"19","author":"Schmidt","year":"1996","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-74","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1529-8027.2010.00294.x","article-title":"Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"15","author":"Chi","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2014-309697-75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1529-8027.2009.00220.x","article-title":"pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"14","author":"Madia","year":"2009","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2014-309697-76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410300110","article-title":"Serum interleukin-2 concentrations in Guillain-Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis","volume":"30","author":"Hartung","year":"1991","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-77","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1179\/1743132812Y.0000000074","article-title":"Proinflammatory cytokines in serum and cerebrospinal fluid of CIDP patients","volume":"34","author":"Rentzos","year":"2012","journal-title":"Neurol Res"},{"key":"key-10.1136\/jnnp-2014-309697-78","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/mus.21786","article-title":"Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy","volume":"42","author":"Gironi","year":"2010","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-79","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2010.05.005","article-title":"The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barr\u00e9 syndrome from chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Sainaghi","year":"2010","journal-title":"Cytokine"},{"key":"key-10.1136\/jnnp-2014-309697-80","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/WNL.56.5.666","article-title":"Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy","volume":"56","author":"Misawa","year":"2001","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-81","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1024532715775","article-title":"Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"23","author":"Press","year":"2003","journal-title":"J Clin Immunol"},{"key":"key-10.1136\/jnnp-2014-309697-82","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/awf070","article-title":"Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10","volume":"125","author":"Kieseier","year":"2002","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-83","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/eji.1830220721","article-title":"Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines","volume":"22","author":"Linington","year":"1992","journal-title":"Eur J Immunol"},{"key":"key-10.1136\/jnnp-2014-309697-84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.410370409","article-title":"Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody","volume":"37","author":"Pollard","year":"1995","journal-title":"Ann Neurol"},{"issue":"(Pt 4)","key":"key-10.1136\/jnnp-2014-309697-85","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/brain\/118.4.857","article-title":"Intraneural activated T cells cause focal breakdown of the blood-nerve barrier","volume":"118","author":"Spies","year":"1995","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-86","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-5728(94)00164-J","article-title":"Synergy between antibody and P2-reactive T cells in experimental allergic neuritis","volume":"57","author":"Spies","year":"1995","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-5728(94)00185-Q","article-title":"Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases","volume":"58","author":"van den Berg","year":"1995","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-88","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2004.10.001","article-title":"Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF","volume":"228","author":"Mei","year":"2005","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-309697-89","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0166-2236(98)01287-9","article-title":"The role of integrins in immune-mediated diseases of the nervous system","volume":"22","author":"Archelos","year":"1999","journal-title":"Trends Neurosci"},{"key":"key-10.1136\/jnnp-2014-309697-90","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.44.5.946","article-title":"Expression of endothelial leukocyte adhesion molecule-1 (ELAM-1) in chronic inflammatory demyelinating polyneuropathy","volume":"44","author":"Oka","year":"1994","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-91","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF02339236","article-title":"Increased serum levels of ICAM-1, ELAM-1 and TNF-alpha in inflammatory disorders of the peripheral nervous system","volume":"15","author":"Musso","year":"1994","journal-title":"Ital J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-309697-92","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.53.1.62","article-title":"Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy","volume":"53","author":"Leppert","year":"1999","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-93","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1212\/WNL.48.4.874","article-title":"Magnetic resonance imaging at the demyelinative foci in chronic inflammatory demyelinating polyneuropathy","volume":"48","author":"Kuwabara","year":"1997","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-94","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/WNL.0b013e318245d250","article-title":"CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"78","author":"Schneider-Hohendorf","year":"2012","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-95","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0165-5728(90)90082-X","article-title":"Quantitative analysis of endoneurial T-cells in human sural nerve biopsies","volume":"26","author":"Cornblath","year":"1990","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-96","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jnnp.69.3.362","article-title":"Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies","volume":"69","author":"Kiefer","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"(Pt 8)","key":"key-10.1136\/jnnp-2014-309697-97","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/brain\/123.8.1660","article-title":"Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy","volume":"123","author":"Murata","year":"2000","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-98","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(99)00009-X","article-title":"TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies","volume":"163","author":"Mathey","year":"1999","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-309697-99","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"Kiefer","year":"2001","journal-title":"Prog Neurobiol"},{"key":"key-10.1136\/jnnp-2014-309697-100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/019131200750060023","article-title":"Chronic inflammatory demyelinating polyneuropathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases","volume":"24","author":"Vital","year":"2000","journal-title":"Ultrastruct Pathol"},{"key":"key-10.1136\/jnnp-2014-309697-101","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/eji.1830180622","article-title":"Specific lysis by CD8+ T cells of Schwann cells expressing Mycobacterium leprae antigens","volume":"18","author":"Steinhoff","year":"1988","journal-title":"Eur J Immunol"},{"key":"key-10.1136\/jnnp-2014-309697-102","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0b013e31827debad","article-title":"Recovery of the T-cell repertoire in CIDP by IV immunoglobulins","volume":"80","author":"Mausberg","year":"2013","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-103","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/08916930903140907","article-title":"Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"42","author":"Sanvito","year":"2009","journal-title":"Autoimmunity"},{"key":"key-10.1136\/jnnp-2014-309697-104","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1529-8027.2008.00158.x","article-title":"Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"13","author":"Chi","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2014-309697-105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1084\/jem.194.5.677","article-title":"Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice","volume":"194","author":"Salomon","year":"2001","journal-title":"J Exp Med"},{"key":"key-10.1136\/jnnp-2014-309697-106","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.20082113","article-title":"A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy","volume":"206","author":"Louvet","year":"2009","journal-title":"J Exp Med"},{"key":"key-10.1136\/jnnp-2014-309697-107","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.4049\/jimmunol.1200493","article-title":"Defective autoimmune regulator-dependent central tolerance to myelin protein zero is linked to autoimmune peripheral neuropathy","volume":"188","author":"Su","year":"2012","journal-title":"J Immunol"},{"key":"key-10.1136\/jnnp-2014-309697-108","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.4049\/jimmunol.1400367","article-title":"Thymic epithelium determines a spontaneous chronic neuritis in Icam1tm1JcgrNOD Mice","volume":"193","author":"Meyer zu","year":"2014","journal-title":"J Immunol"},{"key":"key-10.1136\/jnnp-2014-309697-109","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archneur.1980.00500590061010","article-title":"Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy","volume":"37","author":"Dalakas","year":"1980","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-5728(88)90101-4","article-title":"Immune reactive C3d on the surface of myelin sheaths in neuropathy","volume":"18","author":"Hays","year":"1988","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-111","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8","article-title":"Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients","volume":"47","author":"Yan","year":"2000","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(84)90136-9","article-title":"Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G","volume":"66","author":"Heininger","year":"1984","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-309697-113","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.1129","article-title":"P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Yan","year":"2001","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-114","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1085-9489.2005.0010207.x","article-title":"Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"10","author":"Allen","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2014-309697-115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp.2006.106617","article-title":"Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy","volume":"78","author":"Inglis","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-309697-116","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-5728(93)90255-W","article-title":"Antibody responses to P0 and P2 myelin proteins in Guillain-Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy","volume":"46","author":"Khalili-Shirazi","year":"1993","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-117","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jnnp.2008.159798","article-title":"Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"80","author":"Sanvito","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"(Suppl)","key":"key-10.1136\/jnnp-2014-309697-118","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/ana.410270713","article-title":"Antibodies to gangliosides and myelin proteins in Guillain-Barr\u00e9 syndrome","volume":"27","author":"Quarles","year":"1990","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-119","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0165-5728(01)00307-1","article-title":"Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies","volume":"116","author":"Kwa","year":"2001","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(96)00189-0","article-title":"Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"73","author":"Melendez-Vasquez","year":"1997","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-121","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(99)00269-6","article-title":"Anti-PMP22 antibodies in patients with inflammatory neuropathy","volume":"104","author":"Gabriel","year":"2000","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-122","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(99)00250-7","article-title":"Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies","volume":"104","author":"Ritz","year":"2000","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-123","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-124","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-125","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-126","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2014-309697-127","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0022-510X(87)90235-8","article-title":"P0 myelin protein produces experimental allergic neuritis in Lewis rats","volume":"79","author":"Milner","year":"1987","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-309697-129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/277140a0","article-title":"Identification of the neuritogen for experimental allergic neuritis","volume":"277","author":"Kadlubowski","year":"1979","journal-title":"Nature"},{"issue":"(Pt 10)","key":"key-10.1136\/jnnp-2014-309697-130","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/brain\/121.10.1895","article-title":"Induction of experimental autoimmune neuritis with peripheral myelin protein-22","volume":"121","author":"Gabriel","year":"1998","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-131","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/mus.880080607","article-title":"Endoneurial injection of antisera to myelin antigens","volume":"8","author":"Hughes","year":"1985","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2014-309697-132","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ajpath.2012.06.034","article-title":"Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier","volume":"181","author":"Devaux","year":"2012","journal-title":"Am J Pathol"},{"key":"key-10.1136\/jnnp-2014-309697-133","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1523\/JNEUROSCI.4752-13.2014","article-title":"Long-term maintenance of Na+ channels at nodes of Ranvier depends on glial contact mediated by gliomedin and NrCAM","volume":"34","author":"Amor","year":"2014","journal-title":"J Neurosci"},{"key":"key-10.1136\/jnnp-2014-309697-134","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/glia.20750","article-title":"Molecular domains of myelinated axons in the peripheral nervous system","volume":"56","author":"Salzer","year":"2008","journal-title":"Glia"},{"key":"key-10.1136\/jnnp-2014-309697-135","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1523\/JNEUROSCI.5951-09.2010","article-title":"In vivo deletion of immunoglobulin domains 5 and 6 in neurofascin (Nfasc) reveals domain-specific requirements in myelinated axons","volume":"30","author":"Thaxton","year":"2010","journal-title":"J Neurosci"},{"key":"key-10.1136\/jnnp-2014-309697-136","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.clinph.2013.03.025","article-title":"Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies","volume":"124","author":"Uncini","year":"2013","journal-title":"Clin Neurophysiol"},{"key":"key-10.1136\/jnnp-2014-309697-137","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/WCO.0b013e328357a77f","article-title":"Autoantibodies in immune-mediated neuropathies","volume":"25","author":"Chavada","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-138","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/brain\/awq119","article-title":"Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice","volume":"133","author":"McGonigal","year":"2010","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-139","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/WNL.0000000000000577","article-title":"Antibodies to single glycolipids and glycolipid complexes in Guillain-Barr\u00e9 syndrome subtypes","volume":"83","author":"Shahrizaila","year":"2014","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0000000000000566","article-title":"Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barr\u00e9 syndrome","volume":"83","author":"Sawai","year":"2014","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-309697-141","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jneuroim.2014.09.001","article-title":"Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy","volume":"276","author":"Notturno","year":"2014","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-142","doi-asserted-by":"crossref","first-page":"e14533","DOI":"10.1371\/journal.pone.0014533","article-title":"Nodes of Ranvier and paranodes in chronic acquired neuropathies","volume":"6","author":"Cifuentes-Diaz","year":"2011","journal-title":"PLoS ONE"},{"key":"key-10.1136\/jnnp-2014-309697-143","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jns5.12023","article-title":"Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies","volume":"18","author":"Doppler","year":"2013","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2014-309697-144","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/brain\/awn281","article-title":"Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis","volume":"132","author":"Lonigro","year":"2009","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2014.09.012","article-title":"Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis","volume":"277","author":"Yan","year":"2014","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2014-309697-146","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1083\/jcb.135.5.1355","article-title":"Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+\/third FNIII domain-) and NrCAM at nodal axon segments","volume":"135","author":"Davis","year":"1996","journal-title":"J Cell Biol"},{"key":"key-10.1136\/jnnp-2014-309697-147","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1084\/jem.20071053","article-title":"Neurofascin as a novel target for autoantibody-mediated axonal injury","volume":"204","author":"Mathey","year":"2007","journal-title":"J Exp Med"},{"key":"key-10.1136\/jnnp-2014-309697-148","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/BOR.0b013e3283412fd4","article-title":"What is IgG4? A review of the biology of a unique immunoglobulin subtype","volume":"23","author":"Nirula","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"key-10.1136\/jnnp-2014-309697-149","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/jnnp-2014-309697-150","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1074\/jbc.M113.528489","article-title":"Specific Contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies","volume":"289","author":"Labasque","year":"2014","journal-title":"J Biol Chem"},{"key":"key-10.1136\/jnnp-2014-309697-151","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.expneurol.2013.05.005","article-title":"Neurofascin 186 specific autoantibodies induce axonal injury and exacerbate disease severity in experimental autoimmune encephalomyelitis","volume":"247C","author":"Lindner","year":"2013","journal-title":"Exp Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-152","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0960-9822(01)00680-7","article-title":"Neurofascin is a glial receptor for the paranodin\/Caspr-contactin axonal complex at the axoglial junction","volume":"12","author":"Charles","year":"2002","journal-title":"Curr Biol"},{"key":"key-10.1136\/jnnp-2014-309697-153","doi-asserted-by":"crossref","first-page":"e82337","DOI":"10.1371\/journal.pone.0082337","article-title":"Antibodies to heteromeric glycolipid complexes in Guillain-Barr\u00e9 syndrome","volume":"8","author":"Rinaldi","year":"2013","journal-title":"PLoS ONE"},{"key":"key-10.1136\/jnnp-2014-309697-154","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.it.2013.05.001","article-title":"Glycolipid antigens and autoantibodies in autoimmune neuropathies","volume":"34","author":"Willison","year":"2013","journal-title":"Trends Immunol"},{"key":"key-10.1136\/jnnp-2014-309697-155","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/brain\/124.12.2439","article-title":"Membrane properties in chronic inflammatory demyelinating polyneuropathy","volume":"124","author":"Cappelen-Smith","year":"2001","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-309697-156","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archneurol.2011.137","article-title":"Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy","volume":"68","author":"Lin","year":"2011","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-157","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-158","first-page":"75","article-title":"Conduction of the nerve impulse","volume-title":"Handbook of physiology, Section 1, neurophysiology","author":"Tasaki","year":"1959"},{"key":"key-10.1136\/jnnp-2014-309697-159","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1113\/jphysiol.1985.sp015769","article-title":"Activity-dependent excitability changes in normal and demyelinated rat spinal root axons","volume":"365","author":"Bostock","year":"1985","journal-title":"J Physiol"},{"key":"key-10.1136\/jnnp-2014-309697-160","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/1531-8249(200012)48:6<826::AID-ANA2>3.0.CO;2-P","article-title":"Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy","volume":"48","author":"Cappelen-Smith","year":"2000","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-161","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.clinph.2006.11.013","article-title":"Dynamic change of proximal conduction in demyelinating neuropathies: a cervical magnetic stimulation combined with maximum voluntary contraction","volume":"118","author":"Hitomi","year":"2007","journal-title":"Clin Neurophysiol"},{"key":"key-10.1136\/jnnp-2014-309697-162","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2010.10.008","article-title":"Activity-dependent conduction block in chronic inflammatory demyelinating polyneuropathy","volume":"300","author":"Straver","year":"2011","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-309697-163","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1113\/jphysiol.2004.063966","article-title":"Differences in activity-dependent hyperpolarization in human sensory and motor axons","volume":"558","author":"Kiernan","year":"2004","journal-title":"J Physiol"},{"key":"key-10.1136\/jnnp-2014-309697-164","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1113\/jphysiol.2011.225573","article-title":"The voltage dependence of I(h) in human myelinated axons","volume":"590","author":"Howells","year":"2012","journal-title":"J Physiol"},{"key":"key-10.1136\/jnnp-2014-309697-165","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2377-14-72","article-title":"Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern","volume":"14","author":"Eftimov","year":"2014","journal-title":"BMC Neurol"},{"key":"key-10.1136\/jnnp-2014-309697-166","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3565(25)31336-4","article-title":"Glucocorticoid effects on spinal cord function","volume":"206","author":"Hall","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.1136\/jnnp-2014-309697-167","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0006-8993(81)90311-5","article-title":"Acute enhancement of spinal cord synaptosomal (Na+ + K+)-ATPase activity in cats following intravenous methylprednisolone","volume":"219","author":"Braughler","year":"1981","journal-title":"Brain Res"},{"key":"key-10.1136\/jnnp-2014-309697-168","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0006-8993(82)90648-5","article-title":"Glucocorticoid effects on the electrical properties of spinal motor neurons","volume":"240","author":"Hall","year":"1982","journal-title":"Brain Res"},{"key":"key-10.1136\/jnnp-2014-309697-169","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1152\/ajpregu.00771.2004","article-title":"Contraction-induced increases in Na+-K+-ATPase mRNA levels in human skeletal muscle are not amplified by activation of additional muscle mass","volume":"289","author":"Nordsborg","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2014-309697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T20:02:39Z","timestamp":1747598559000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2014-309697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,12]]},"references-count":169,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,8,13]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1136\/jnnp-2014-309697"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2014-309697","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,12]]}}}